Oncocyte Corp Stock Market Value
| OCX Stock | USD 2.44 0.09 3.56% |
| Symbol | OncoCyte |
OncoCyte Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OncoCyte Corp. If investors know OncoCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OncoCyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.44) | Revenue Per Share 0.066 | Quarterly Revenue Growth (0.73) | Return On Assets (0.19) | Return On Equity (1.65) |
The market value of OncoCyte Corp is measured differently than its book value, which is the value of OncoCyte that is recorded on the company's balance sheet. Investors also form their own opinion of OncoCyte Corp's value that differs from its market value or its book value, called intrinsic value, which is OncoCyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OncoCyte Corp's market value can be influenced by many factors that don't directly affect OncoCyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OncoCyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if OncoCyte Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OncoCyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OncoCyte Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OncoCyte Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OncoCyte Corp.
| 05/31/2024 |
| 11/27/2024 |
If you would invest 0.00 in OncoCyte Corp on May 31, 2024 and sell it all today you would earn a total of 0.00 from holding OncoCyte Corp or generate 0.0% return on investment in OncoCyte Corp over 180 days. OncoCyte Corp is related to or competes with Burning Rock, Neuronetics, DarioHealth Corp, Sera Prognostics, Fonar, Castle Biosciences, and Exagen. OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-d... More
OncoCyte Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OncoCyte Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OncoCyte Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 18.12 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 4.59 |
OncoCyte Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OncoCyte Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OncoCyte Corp's standard deviation. In reality, there are many statistical measures that can use OncoCyte Corp historical prices to predict the future OncoCyte Corp's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (28.87) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OncoCyte Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OncoCyte Corp Backtested Returns
OncoCyte Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. OncoCyte Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OncoCyte Corp's Coefficient Of Variation of (1,152), risk adjusted performance of (0.06), and Variance of 9.68 to confirm the risk estimate we provide. The company holds a Beta of 0.0097, which implies not very significant fluctuations relative to the market. As returns on the market increase, OncoCyte Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding OncoCyte Corp is expected to be smaller as well. At this point, OncoCyte Corp has a negative expected return of -0.35%. Please make sure to check OncoCyte Corp's maximum drawdown, as well as the relationship between the daily balance of power and relative strength index , to decide if OncoCyte Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.31 |
Poor reverse predictability
OncoCyte Corp has poor reverse predictability. Overlapping area represents the amount of predictability between OncoCyte Corp time series from 31st of May 2024 to 29th of August 2024 and 29th of August 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OncoCyte Corp price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current OncoCyte Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
OncoCyte Corp lagged returns against current returns
Autocorrelation, which is OncoCyte Corp stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting OncoCyte Corp's stock expected returns. We can calculate the autocorrelation of OncoCyte Corp returns to help us make a trade decision. For example, suppose you find that OncoCyte Corp has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
OncoCyte Corp regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If OncoCyte Corp stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if OncoCyte Corp stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in OncoCyte Corp stock over time.
Current vs Lagged Prices |
| Timeline |
OncoCyte Corp Lagged Returns
When evaluating OncoCyte Corp's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of OncoCyte Corp stock have on its future price. OncoCyte Corp autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, OncoCyte Corp autocorrelation shows the relationship between OncoCyte Corp stock current value and its past values and can show if there is a momentum factor associated with investing in OncoCyte Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OncoCyte Stock Analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.